Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 5943-5951

  Behrens, Lüder ^a   Kerschensteiner, Martin ^a   Misgeld, Thomas ^a   Goebels, Norbert ^a,b   Wekerle, Hartmut ^a   Hohlfeld, Reinhard ^a,b  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; B7 ANTIGEN; BASIC FIBROBLAST GROWTH FACTOR; CD86 ANTIGEN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; HLA DR3 ANTIGEN; INTERLEUKIN 4; LAMININ;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL INCLUSION; CONFOCAL LASER MICROSCOPY; CROSS REACTION; DERMATOMYOSITIS; DNA SYNTHESIS; HEREDITARY SPINAL MUSCULAR ATROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBIOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE BIOPSY; MUSCLE CELL; MYOBLAST; MYOPATHY; NUCLEOTIDE SEQUENCE; POLYMYOSITIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN-4; KINETICS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOSITIS; TIME FACTORS;

EID: 0032400949     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hohlfeld, R., and A. G. Engel. 1994. The immunobiology of muscle. Immunol. Today 15:269.
2. Kumar, V., and E. Sercarz. 1996. Genetic vaccination: the advantages of going naked. Nat. Med. 2:857.
3. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165.
4. Engel, A. G., R. Hohlfeld, and B. Q. Banker. 1994. The polymyositis and dermatomyositis syndromes. In Myology. 2nd ed. A.G. Engel and C. Franzini-Armstrong, eds. McGraw Hill, New York, p. 1335.
5. Dalakas, M. C. 1991. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325:1487.
6. Miller, J. B., and F. M. Boyce. 1995. Gene therapy by and for muscle cells. Trends Genet. 11:163.
7. Blau, H. M., and M. L. Springer. 1995. Muscle-mediated gene therapy. N. Engl. J. Med. 333:1554.
8. Goebels, N., D. Michaelis, H. Wekerle, and R. Hohlfeld. 1992. Human myoblasts as antigen-presenting cells. J. Immunol. 149:661.
9. Yokochi, T., R. D. Holly, and E. A. Clark. 1982. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B blastoid cell lines, and Burkitt's lymphoma. J. Immunol. 128:523.
10. Boussiotis, V. K., G. J. Freeman, J. G. Gribben, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90:11059.
11. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87:5031.
12. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. Involvement of CD28 in major histocompatibility complex-unrestricted cytotoxicity mediated by a human NK leukemia cell line. J. Immunol. 149:1115.
13. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
14. Garrone, P., E. M. Neidhardt, E. Garcia, L. Galibert, C. Van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265.
15. Meinl, E., F. Weber, K. Drexler, C. Morelle, M. Ott, G. Saruhan-Direskeneli, N. Goebels, B. Ertl, G. Jechart, G. Giegerich, S. Schönbeck, W. Bannwarth, H. Wekerle, and R. Hohlfeld. 1993. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis: complexity of response and dominance of nested epitopes due to recruitment of multiple T cell clones. J. Clin. Invest. 92:2633.
16. Nakajima-Iijima, S., H. Hamada, P. Reddy, and T. Kakunaga. 1985. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA 82:6133.
17. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
18. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
19. Denfeld, R. W., A. Dietrich, C. Wuttig, E. Tanczos, J. M. Weiss, W. Vanscheidt, E. Schöpf, and J. C. Simon. 1995. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell mediated anti-tumor immunity. Int. J. Cancer 62:259.
20. Thurnher, M., C. Radmayr, A. Hobisch, G. Böck, N. Romani, G. Bartsch, and H. Klocker. 1995. Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T cell expansion by T-T cell co-stimulation. Int. J. Cancer 62:559.
21. Bernasconi, P., P. Confalonieri, F. Andreetta, F. Baggi, F. Cornelio, and R. Mantegazza. 1998. The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: relevance for the pathogenesis of inflammatory myopathy. J. Neuroimmunol. 85:52.
22. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 152:5723.
23. Kawamura, T., and M. Furue. 1995. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur. J. Immunol. 25:1913.
24. Junghans, V., T. Jung, and C. Neumann. 1996. Human keratinocytes constitutively express IL-4 receptor molecules and respond to IL-4 with an increase of B7/BB1 expression. Exp. Dermatol. 5:316.
25. Roy, M., A. Aruffo, J. A. Ledbetter, P. S. Linsley, M. R. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7-1 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
26. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
27. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862.
28. Grewal, I. S., H. G. Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janeway, and R. A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864.
29. Banchereau, J., F. Bazan, D. Blanchard, F. Brière, J.-P. Galizzi, C. Van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
30. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
31. Reiser, H., and M. J. Stadecker. 1996. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 333:1369.
32. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979.
33. Bluestone, J. A. 1995. New perspectives of CD28/B7-mediated T cell costimulation. Immunity 2:855.
34. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1998. The B7 and CD28 receptor families. Immunol. Today 15:321.
35. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
36. Freeman, G. J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L.-J. Zhou, M. White, J. D. Fingeroth, J. G. Gribben, and L. M. Nadler. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
37. Nickoloff, B. J., R. S. Mitra, K. Lee, L. A. Turka, J. Green, C. Thompson, and Y. Shimizu. 1993. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol. 142:1029.
38. Murakami, M., Y. Takahashi, Y. Isashi, S. Kon, W.-Y. Jia, M. Inobe, R. Abe, and T. Uede. 1996. Identification and characterization of an alternative cytotoxic lymphocyte-associated protein 4 molecule on B cells. Proc. Natl. Acad. Sci. USA 93:7838.
39. Blau, H. M., and C. Webster. 1981. Isolation and characterization of human muscle cells. Proc. Natl. Acad. Sci. USA 78:5623.
40. Illa, I., M. Leon-Monzon, and M. C. Dalakas. 1992. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies and natural killer cells. Ann. Neurol. 31:46.
41. Curnow, S. J., N. Willcox, and A. Vincent. 1998. Induction of primary immune responses by allogeneic human myoblasts: dissection of the cell types required for proliferation, IFN-γ secretion, and cytotoxicity. J. Neuroimmunol. 86:53.
42. Valle, M. T., M. L. Degl'Innocenti, R. Bertelli, P. Facchetti, F. Perfumo, D. Fenoglio, A. Kunkl, R. Gusmano, and F. Manca. 1995. Antigen-presenting function of human peritoneum mesothelial cells. Clin. Exp. Immunol. 101:172.
43. Laman, J. D., E. Claassen, and R. J. Noelle. 1996. Functions of CD40 and its ligand, gp39 (CD40L). CRC Crit. Rev. Immunol. 16:59.
44. + T cell responses. Immunol. Today 17:410.
45. Dalakas, M. C., and K. Sivakumar. 1996. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr. Opin. Neurol. 9:235.
46. Miller, F. W. 1993. Myositis specific autoantibodies: touchstones for understanding the inflammatory myopathies. JAMA 270:1846.
47. Hohlfeld, R., A. G. Engel, N. Goebels, and L. Behrens. 1997. Cellular immune mechanisms in inflammatory myopathies. Curr. Opin. Rheumatol. 9:520.
48. + T cells. J. Exp. Med. 181:1863.
49. Goebels, N., D. Michaelis, M. Engelhardt, S. Huber, A. Bender, D. Pongratz, M. A. Johnson, H. Wekerle, J. Tschopp, D. Jenne, and R. Hohlfeld. 1996. Differential expression of perform in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 97:2905.
50. Mendoza, R. B., M. J. Cantwell, and T. J. Kipps. 1997. Immunostimulatory effects of a plasmid-expressing CD40 ligand (CD154) on gene immunization. J. Immunol. 159:5777.
51. Freeman, G. J., A. A. Cardoso, V. A. Boussiotis, A. Anumanthan, R. W. Graves, T. S. Kupper, E. A. Clark, and L. M. Nadler. 1998. The BBI monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated in variant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J. Immunol. 161:2708.